Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
24
TGA:24
Drug Approvals
BYLVAY odevixibat 600 microgram capsule bottle (419593)
- Product Name
- BYLVAY odevixibat 600 microgram capsule bottle
- Approval Date
- Mar 26, 2025
TGA
BYLVAY odevixibat 200 microgram capsule bottle (419590)
- Product Name
- BYLVAY odevixibat 200 microgram capsule bottle
- Approval Date
- Mar 26, 2025
TGA
BYLVAY odevixibat 1200 microgram capsule bottle (419592)
- Product Name
- BYLVAY odevixibat 1200 microgram capsule bottle
- Approval Date
- Mar 26, 2025
TGA
BYLVAY odevixibat 400 microgram capsule bottle (419591)
- Product Name
- BYLVAY odevixibat 400 microgram capsule bottle
- Approval Date
- Mar 26, 2025
TGA
IQIRVO elafibranor 80 mg film-coated tablets bottle (441770)
- Product Name
- IQIRVO elafibranor 80 mg film-coated tablets bottle
- Approval Date
- Mar 25, 2025
TGA
RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial (405864)
- Product Name
- RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial
- Approval Date
- Jul 1, 2024
TGA
SOHONOS palovarotene 1.5 mg capsule blister pack (394001)
- Product Name
- SOHONOS palovarotene 1.5 mg capsule blister pack
- Approval Date
- Nov 28, 2023
TGA
SOHONOS palovarotene 5 mg capsule blister pack (394000)
- Product Name
- SOHONOS palovarotene 5 mg capsule blister pack
- Approval Date
- Nov 28, 2023
TGA
SOHONOS palovarotene 1 mg capsule blister pack (394003)
- Product Name
- SOHONOS palovarotene 1 mg capsule blister pack
- Approval Date
- Nov 28, 2023
TGA
SOHONOS palovarotene 10 mg capsule blister pack (393999)
- Product Name
- SOHONOS palovarotene 10 mg capsule blister pack
- Approval Date
- Nov 28, 2023
TGA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)No trials found
News
No news found